Association between continuous glucose monitoring-derived time in range, other core metrics, and albuminuria in type 2 diabetes
Yoo JH, Choi MS, Ahn J, Park SW, et al.
Diabetes Technol Ther. Pub online 13 March 2020
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Serum 25-hydroxyvitamin D concentration in childhood and risk of islet autoimmunity and type 1 diabetes: the TRIGR nested case–control ancillary study
Miettinen ME, Niinistö S, Erlund I, et al.
Diabetologia. 2020;63(4):780-87
Leggi
Risk of hypoglycaemia with insulin degludec versus insulin glargine U300 in insulin-treated patients with type 2 diabetes: the randomised, head-to-head CONCLUDE trial
Colombo M, McGurnaghan SJ, Blackbourn LAK, et al.
Diabetologia. 2020;63(4):788-98
Leggi
Comparison of serum and urinary biomarker panels with albumin/creatinine ratio in the prediction of renal function decline in type 1 diabetes
Colombo M, McGurnaghan SJ, Blackbourn LAK, et al.
Diabetologia. 2020;63(4):788-98
Leggi
Accuracy of freestyle libre in adults with type 1 diabetes: the effect of sensor age
Tsoukas M, Rutkowski J, El-Fathi A, et al.
Diabetes Technol Ther. 2020;22(3):203-7
Leggi
Demonstrated cost-effectiveness of a telehomecare program for gestational diabetes mellitus management
Lemelin A, Paré G, Bernard S, Godbout A
Diabetes Technol Ther. 2020;22(3):195-202
Leggi
Efficacy and safety of SGLT2 inhibitors in type 1 diabetes after the introduction of an off-label use protocol for clinical practice
Bayona Cebada A, Nattero-Chávez L, et al.
Diabetes Technol Ther. 2020;22(3):208-15
Leggi
Safety and performance of the omnipod hybrid closed-loop system in adults, adolescents, and children with type 1 diabetes over 5 days under free-living conditions
Sherr JL, Buckingham BA, Forlenza GP, et al.
Diabetes Technol Ther. 2020;22(3):174-84
Leggi
Fifteen-year trends of cardiogenic shock and mortality in patients with diabetes and acute coronary syndromes
Dauriz M, Morici N, Gonzini L et al.
Am J Med. 2020;133(3):331-339.e2
Leggi
Does metformin interfere with the cardiovascular benefits of SGLT2 inhibitors? Questions about its role as the cornerstone of diabetes treatment
Packer M
American Journal of Medicine. Pub online 12 February 2020
Leggi